Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Abivax reports positive topline results from ABX464-101 trial for UC

Active phase of chronic ulcerative colitis. Credit: Ed Uthman.

Go Top